Aberration ofp73promoter methylation inde novomyelodysplastic syndrome

Aberrant Methylation of Death-Associated Protein Kinase 1 CpG Islands in Myelodysplastic Syndromes

(2011) Xueqiong Wu et al.   ACTA HAEMATOLOGICA

Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia

(2011) Elizabeth A. Griffiths et al.   Epigenetics

Epigenetic inactivation of tumour suppressor geneKLF11in myelodysplastic syndromes

(2009) Anna Potapova et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes

(2009) Lanlan Shen et al.   JOURNAL OF CLINICAL ONCOLOGY

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

(2008) D. E. Rollison et al.   BLOOD

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML

(2008) Y. Jiang et al.   BLOOD

Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome

(2008) Jiang Lin et al.   LEUKEMIA RESEARCH